Evidence map›Paper›PMID 37221835›Full record

ArticleVirulence2023

Evolution of

Shamira J Shallom, Hervé Tettelin, Prabha Chandrasekaran, In Kwon Park, Sonia Agrawal, Kriti Arora, Lisa Sadzewicz, Aaron M Milstone, Moira L Aitken, Barbara A Brown-Elliott and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Evolution toward extremely high imipenem resistance inAntimicrobial agents and chemotherapy · 2024
    Article
  5. Article
  6. Evolution towards extremely high β-lactam resistance inbioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Shamira J ShallomMicrobiology Service, Department of Laboratory Medicine (DLM), Clinical Center, NIH, Bethesda, MD, USA.
Hervé TettelinInstitute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Prabha ChandrasekaranLaboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.
In Kwon ParkLaboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.
Sonia AgrawalInstitute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Kriti AroraLaboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.
Lisa SadzewiczInstitute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Aaron M MilstonePediatric Infectious Diseases, Johns Hopkins University, Baltimore, MD, USA.
Moira L AitkenDivision of Pulmonary and Critical Care Medicine, University of Washington Medical Center, Seattle, WA, USA.
Barbara A Brown-ElliottMycobacteria/Nocardia Laboratory, University of Texas Health Science Center, Tyler, TX, USA.
Richard J WallaceMycobacteria/Nocardia Laboratory, University of Texas Health Science Center, Tyler, TX, USA.
Elizabeth P SampaioLaboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.
Michael NiederweisDepartment of Microbiology, University of Alabama, Birmingham, England.
Kenneth N OlivierLaboratory of Chronic Airway Infection, Pulmonary Branch, National Heart Lung and Blood Institute (NHLBI), NIH, Bethesda, MD, USA.
Steven M HollandLaboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.
Adrian M ZelaznyMicrobiology Service, Department of Laboratory Medicine (DLM), Clinical Center, NIH, Bethesda, MD, USA.
National Institute of Allergy and Infectious Diseases · USUniversity of Maryland, Baltimore · USNational Institutes of Health Clinical Center · USThe University of Texas Health Science Center at Tyler · USJohns Hopkins University · USNational Heart Lung and Blood Institute · USUniversity of Alabama · USUniversity of Washington Medical Center · US

Funding

Molecular and Virulence Traits of Bacteria & Fungi Causing Persistent InfectionsZIACL080013 · CLC · CLINICAL CENTER · PI ZELAZNY, ADRIAN MARCELO · 2009 to 2025
$0k
6 · The paper itself

Abstract

background

resultsComparative genomic analysis revealed the mutations affecting growth rate, metabolism, transport, lipids (loss of glycopeptidolipids), antibiotic susceptibility (macrolides and aminoglycosides resistance), and virulence factors. Mutations in 23S rRNA,

conclusionsWe hypothesize that specific mutations accumulated and maintained over time in

Indexed as

Cystic FibrosisMycobacteriumMycobacterium abscessusAnti-Bacterial AgentsGenomicsGlucoseHumansLungMutationPorinsTumor Necrosis Factor-alphaAnti-Bacterial AgentsGlucosePorinsTumor Necrosis Factor-alphacystic fibrosisimmune responseMycobacterium abscessusMycobacterium massiliensePorinwhole genome sequencing

Identifiers

PMID37221835
PMCPMC10243398
OpenAlexW4377941055

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.